Who owns MOLECULIN BIOTECH INC?
- Ticker: MBRX
- CUSIP Number: 60855d408
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 47k | $132k | 46% | Jun 2026 |
|
| Vanguard Capital Management | 42k | $118k | 204% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 30k | $83k | 392% | Jun 2026 |
|
| XTX Topco | 23k | $64k | 100% | Jun 2026 |
|
| Rockefeller Capital Management | 15k | $42k | 239% | Jun 2026 |
|
| Tower Research Capital | 3.5k | $9.8k | 91% | Jun 2026 |
|
| Barclays | 621.00 | $1.7k | 100% | Jun 2026 |
|
| BlackRock | 491.00 | $1.4k | 0% | Jun 2026 |
|
| EFG International | 434.00 | $1.2k | 0% | Jun 2026 |
|
| Jones Financial Companies, L.L | 360.00 | $1.2k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 200.00 | $558.000000 | 100% | Jun 2026 |
|
| Newbridge Financial Services Group | 114.00 | $318.003000 | 0% | Jun 2026 |
|
| SBI Securities | 44.00 | $123.002000 | 2% | Jun 2026 |
|
| Morgan Stanley | 36.00 | $82.800000 | 0% | Mar 2026 |
|
| Danske Bank A/s | 2.00 | $6.000000 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 1.00 | $2.000000 | 0% | Jun 2026 |
|
| CVA Family Office | 1.00 | $3.000000 | 0% | Jun 2026 |
|
Who sold out of Moleculin Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sabby Management | Mar 2026 | 75k | $172k |
| Hrt Financial | Mar 2026 | 14k | $31k |
| UBS Group | Mar 2026 | 3.4k | $7.8k |
| Pinnacle Wealth Planning Services | Mar 2026 | 281.00 | $643.012300 |
| Vanguard Global Advisers | Mar 2026 | 24.00 | $55.000800 |
| FMR | Mar 2026 | 3.00 | $6.999900 |
| Caitong International Asset Management | Mar 2026 | 2.00 | $5.000000 |